These results are indicative of a MERRF metabolic profile characterized by increased lipolysis and fatty acid availability (Fig 5L), elevated FGF21 (Fig 4K), and hypercortisolemia (Fig 7G), which stimulates ketogenesis. The gene discussed is FGF21; the disease is adrenal gland hyperfunction.